Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements

CME logo image
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Img, 2009; 2:592-599, doi:10.1016/j.jcmg.2009.03.007
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Høfsten, D. E.
Right arrow Articles by Egstrup, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Høfsten, D. E.
Right arrow Articles by Egstrup, K.
Related Collections
Right arrowRelated Article

Abnormal Glucose Metabolism in Acute Myocardial Infarction

Influence on Left Ventricular Function and Prognosis

Dan E. Høfsten, MD, PhD*,*, Brian B. Løgstrup, MD*, Jacob E. Møller, MD, PhD{dagger}, Patricia A. Pellikka, MD{ddagger}, Kenneth Egstrup, MD, DMsc*

* Department of Medical Research, Funen Hospital, Svendborg, Denmark
{dagger} Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
{ddagger} Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota

* Reprint requests and correspondence: Dr. Dan E. Høfsten, Department of Medical Research, Funen Hospital Svendborg, 5700 Svendborg, Denmark (Email: dan{at}hoefsten.dk).

Objectives: We studied the influence of abnormal glucose metabolism on left ventricular (LV) function and prognosis in 203 patients with acute myocardial infarction.

Background: Abnormal glucose metabolism is associated with increased mortality after acute myocardial infarction. This appears to be particularly attributable to an increased incidence of post-infarction congestive heart failure. A relationship between glucose metabolism and LV function could potentially explain this excess mortality.

Methods: In patients without known diabetes, glucose metabolism was determined using an oral glucose tolerance test before discharge. LV function was assessed using echocardiographic measurements (LV end-diastolic volume, LV end-systolic volume, LV ejection fraction, restrictive diastolic filling pattern, early transmitral flow velocity to early diastolic mitral annular velocity ratio [E/e'], and left atrial volume index) and by measuring plasma N-terminal pro-B-type natriuretic peptide levels.

Results: After adjustment for age and gender, a linear relationship between the degree of abnormal glucose metabolism was observed for each marker of LV dysfunction (ptrend < 0.05) with the exception of left atrial volume index (p = 0.10). During a median follow-up of 21 months, 32 patients died, and 39 patients met the secondary end point of death or hospitalization for heart failure. After adjustment for differences in LV function, as well as other relevant characteristics, newly detected, as well as known diabetes were independent predictors of both all-cause mortality (hazard ratios [HR]: 4.2 [95% confidence interval (CI): 1.1 to 17.1] and HR: 5.7 [95% CI: 1.3 to 25.2], respectively), and the composite of death or hospitalization for heart failure (HR: 4.3 [95% CI: 1.2 to 15.6] and HR: 5.8 [95% CI: 1.5 to 22.3], respectively). Comparable nonsignificant trends were observed for patients with impaired glucose tolerance.

Conclusions: Although perturbations in glucose metabolism were linearly associated with impairment of LV function in the early phase of acute myocardial infarction, this relationship alone did not explain the excess mortality in patients with newly detected or known diabetes.

Key Words: myocardial infarction • glucose • echocardiography • heart failure • prognosis

Abbreviations and Acronyms
  AMI = acute myocardial infarction
  DM = diabetes mellitus
  EDT = E-wave deceleration time
  E/e' = early transmitral flow velocity to early diastolic mitral annular velocity ratio
  IFG = impaired fasting glycemia
  IGT = impaired glucose tolerance
  LV = left ventricle
  LVEF = left ventricular ejection fraction
  NT-proBNP = N-terminal pro-B-type natriuretic peptide
  OGTT = oral glucose tolerance test


Related Article

Dysglycemia and Acute Myocardial Infarction: The Role of Echocardiography
David Verhaert and James D. Thomas
J. Am. Coll. Cardiol. Img. 2009 2: 600-603. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
D. Verhaert and J. D. Thomas
Dysglycemia and acute myocardial infarction the role of echocardiography.
J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 600 - 603.
[Full Text] [PDF]



Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link